Skip to main content

Table 1 Patient characteristics

From: CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations

Variable Number of patients
Age [median (range), years] 38.5 (23–61)
Male/female 14/8
Diagnosis
 AML/MDS 14
 ALL/ML 8
Donor
 Related 10
 Unrelated 12
Source
 BMT 14
 PBSCT 8
HLA compatibility
 Matched 17
 1-locus mismatch 5
Conditioning
 Myeloablative 14
  TBI/CY-based 10
  BU/CY 4
 Reduced-intensity 8
  TBI/Flu/BU 4
  TBI/Flu/Mel 4
GVHD prophylaxis
 CyA/MTX 3
 TAC/MTX 19
  1. AML/MDS acute myeloid leukemia/myelodysplastic syndromes, ALL/ML acute lymphoblastic leukemia/malignant lymphoma, BMT bone marrow transplantation, PBSCT peripheral blood stem cell transplantation, HLA human leukocyte antigen, TBI total body irradiation, CY cyclophosphamide, BU Busulfan, Mel melphalan, GVHD graft-versus-host disease, CyA cyclosporine A, MTX methotrexate, TAC tacrolimus.